CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-08